IMMUNODEFICIENCY

Clinical trials for IMMUNODEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new IMMUNODEFICIENCY trials appear

Sign up with your email to follow new studies for IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug could make stem cell transplants safer for rare immune disease

⭐️ CURE ⭐️ Ongoing

This study tests a drug called Briquilimab to see if it can make stem cell transplants safer for people with GATA2 deficiency, a genetic condition that weakens the immune system and raises the risk of serious infections and blood cancers. About 7 people aged 6 to 70 will receive …

Matched conditions: IMMUNODEFICIENCY

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ CURE ⭐️

Last updated Apr 29, 2026 01:36 UTC

IMMUNODEFICIENCY

Get alerted when new IMMUNODEFICIENCY trials appear

New drug could make stem cell transplants safer for rare immune disease